1. Home
  2. TNXP vs ATLO Comparison

TNXP vs ATLO Comparison

Compare TNXP & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$15.63

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$22.95

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
ATLO
Founded
2007
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.9M
205.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TNXP
ATLO
Price
$15.63
$22.95
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$70.00
N/A
AVG Volume (30 Days)
507.7K
30.2K
Earning Date
11-10-2025
01-23-2026
Dividend Yield
N/A
3.48%
EPS Growth
N/A
82.57
EPS
N/A
1.80
Revenue
$10,299,000.00
$60,568,000.00
Revenue This Year
$2.96
N/A
Revenue Next Year
$750.19
N/A
P/E Ratio
N/A
$12.82
Revenue Growth
N/A
18.60
52 Week Low
$6.76
$16.04
52 Week High
$69.97
$24.36

Technical Indicators

Market Signals
Indicator
TNXP
ATLO
Relative Strength Index (RSI) 36.58 54.46
Support Level $15.47 $22.62
Resistance Level $16.95 $23.42
Average True Range (ATR) 0.96 0.48
MACD -0.21 -0.12
Stochastic Oscillator 5.90 28.31

Price Performance

Historical Comparison
TNXP
ATLO

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: